Mapp Biopharmaceutical
Press Inquiries
  • About Us
  • Product Development
  • News
    • In the News
    • Press Releases
  • Publications
  • Job Openings
  • Contact Us
MappBio Announces Contract with BARDA for Sudan Ebolavirus Medical Countermeasure

MappBio Announces Contract with BARDA for Sudan Ebolavirus Medical Countermeasure

by Mapp Admin | Sep 28, 2018 | Press Releases

MappBio Announces Contract with BARDA for Sudan Ebolavirus Medical Countermeasure September 28, 2018 – (SAN DIEGO, CA) – Mapp Biopharmaceutical, Inc. (MappBio), announced today that it has been awarded a contract (HHSO100201800024C) of $14.8 million with options for...

read more

Archives

  • October 2022
  • January 2021
  • June 2019
  • January 2019
  • September 2018

Categories

  • Press Releases

Recent News

BARDA collaborates with Mapp Biopharmaceutical, Inc. to advance the development of a therapeutic for Marburg virus disease

Oct 27, 2022

BARDA collaborates with Mapp Biopharmaceutical, Inc. to advance the development of a therapeutic for Marburg virus disease           To further enhance preparedness against health security threats, BARDA is extending a partnership with Mapp...

ASPR awards $110 million to advance development, procure therapeutic for Sudan ebolavirus

Oct 4, 2022

ASPR awards $110 million to advance development, procure therapeutic for Sudan ebolavirus     The Administration for Strategic Preparedness and Response (ASPR) today announced a $109.8 million contract with Mapp Biopharmaceutical Inc., for the advanced...

Additional Information

  • FCOI Policy
  • Purchase Order Terms and Conditions
  • Pay Transparency Nondiscrimination Provision
  • Equal Employment Opportunity is the Law
  • Institutional Biosafety Committee (NIH)
  • Employment of Individuals with Disabilities and Protected Veterans
  • Equal Employment Opportunity and Affirmative Action Policy Statement
  • Expanded Access Policy
Jobs Opportunities

© 2017-2022 Mapp Biopharmaceutical. All Rights Reserved.